AI can cut surgical waiting lists

Artificial intelligence designed to identify patients suitable for joint replacement surgery has the potential to significantly cut waiting times and improve surgical efficiency, new research from the University of Aberdeen suggests.

© Aristal/Pixabay

© Aristal/Pixabay

Artificial intelligence designed to identify patients suitable for joint replacement surgery has the potential to significantly cut waiting times and improve surgical efficiency, new research from the University of Aberdeen suggests.

The study found that using the Aberdeen-led AI could help to ‘rapidly' and ‘accurately' identify patients that are suitable for hip replacement surgery.    

Dr Luke Farrow, clinical research fellow from the University of Aberdeen and study lead, said: ‘We identified that the radiologist's summary of x-ray findings can be successfully used to help predict which patients referred for consideration of hip replacement will go on to have surgery.'  

The research found that the AI needs to be trained according to the specific characteristics of the healthcare setting it is to be used in.  

Dr Farrow added: 'The effectiveness of the developed AI algorithm deteriorated significantly when faced with radiology reports from a different healthcare setting, indicating a need for further training on a wider, more diverse population.

'Further development is needed to ensure that the algorithm works better when applied to new healthcare settings, such as different NHS trusts. With any AI algorithm it is important to ensure that it functions effectively in the real world.'   

Dentistry becoming 'two-tier service', Nuffield Trust finds

Dentistry becoming 'two-tier service', Nuffield Trust finds

By Lee Peart 24 August 2026

Dentistry is ‘quietly being transformed into a two-tier service’, according to Nuffield Trust analysis.

Doctors enter formal dispute over funding cuts

By Lee Peart 19 August 2026

Doctors in Cheshire and Merseyside have entered a formal dispute with the secretary of state for health and social care over money saving targets.

MHRA clarifies licencing route for microbiome-based medicines

By Lee Peart 18 August 2026

The MHRA has clarified its position on the UK licencing route for microbiome-based medicines.


Popular articles by Liz Wells